(Picture: Mercury Press)
On 19 June, Daniel Farbace passed away after contracting parainfluenza, while also battling acute myloid leukaemia. He was just 21 months old.
His mum, Ali Farbace, has shared a photograph of herself kissing her son goodbye as a way to celebrate his life.
His last act was to save us, says Ali, 35, explaining that by passing away, Daniel had saved his parents from the impossible decision to turn off their childs life support.
When people say things like sorry for your loss I dont really like that.
He never lost at anything we think he sacrificed himself for us.
Hes made it a lot easier for us. My feeling was that I wanted him to have quality of life, but it was stacking up against him, it wasnt fair.
We just didnt want him to suffer.
If we had had to make the decision to turn the machine off then we would never have forgiven ourselves. I do think he has saved us from that.
Ali and her husband, Dan, spent nine days with Daniels body after he died, staying to make memories with their child at Demelza Childrens Hospice in Sittingborne Kent from 19 June to 26 June.
On the ninth day, Ali and Dan brought Daniels body home to have a funeral.
It would have broken us to go home straight away with nothing, said Ali. When we got to Demelza it was just perfect. To spend that time with Daniel was lovely.
We sang, and talked to him and read to him. We got so much more time. I didnt want to leave him on his own. He was so beautiful.
He had never spent a day apart from me. He had his own bedroom, he was still a person, and it was so nice to see him without the tubes.
Our friends got to come and visit too, and we really got to say goodbye.
The night before his funeral he came home for the night. We were just glad we could all come home together. To spend our last night together was really nice.
Its cr*p, and wed do anything to have him back, but some children dont get to go home.
Despite being on life support for nine days, Daniels death still came as a surprise.
When he was born on 29 September 2015 at 26 weeks, Daniel had to be resuscitated and was on a ventilator for 16 days. He survived that, went home, but had to return to hospital in April 2016 when his parents noticed pin prick marks on his skin.
Doctors initially thought it could just be a viral rash, but soon lumps developed.
He was admitted to Great Ormond Street Hospital in April, where doctors investigated possibilities of Daniel having leukemia and neuroblastoma.
On 19 April Dan and Ali were told Daniel had leukemia, with an official diagnosis on 21 April.
It was unusual because the leukaemia was presenting as something else, said Ali.
They told us it was treatable, they gave him a 68 to 72 per cent chance he would survive.
It was just awful. Everything gets taken out of your hands. We just wanted our baby.
AML is an aggressive, rare cancer that affects the blood. Stem cells found in bone marrow produce too many immature white blood cells which are called blast cells.
The blast cells are unable to properly fight off infection, and if too many are produced the number of oxygen-carrying red blood cells and platelets, which clot the blood, can be reduced.
Symptoms of the illness include pale skin, tiredness, frequent infections, and breathlessness.
In severe cases AML can make sufferers extremely vulnerable to life-threatening infections. A bone marrow or stem cell transplant may be necessary alongside chemotherapy or radiotherapy to combat the illness.
After four courses of chemotherapy, Daniel seemed to be getting better. He was even able to go home for his first birthday.
But seven months later, the leukemia had returned, this time bringing a lump in Daniels brain with it.
After numerous chemotherapy treatments to battle theacute myloid leukaemia that had spread to Daniels blood and bone marrow, Daniel contracted parainfluenza.
Unable to fight off the infection, he spent nine days on life support before passing away.
He was on life support for nine days, there were so many times when I thought, he was going to die, said Ali.
Then the day he did die we didnt expect it. We just thought, You little b*gger.
I got to carry him across the corridor to the hospital cold room, which was an honour.
Its quite hard coping with death, he was still our baby.
We shared that picture to show the story goes on after death. People have been so supportive.
Dan said that picture looks like when they used to lay warriors to rest and Daniel was a fighter.
He was always happy and always smiling. I know it sounds crazy, but he never really seemed that unwell. When he was sick he was just quiet.
Now, Ali and Dan want to keep their sons legacy alive by using his story to raise awareness about blood and bone marrow donation.
So far, Daniel has helped to raise over 25,000 for charity.
We just want to get the message out about donating blood and bone marrow transplant now, says Ali.
Sometimes Daniel had to wait 12 hours for transfusions. But he would have died a long time ago if it hadnt have been for donors.
MORE: Woman explains how makeup makes her feel confident with a feeding tube
MORE: Mum shares what really goes on behind her perfect Instagram photos
MORE: All parents will recognise the pain of having to clean a kid up covered in Sudocrem
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021